Scientist, Sidney Kimmel Cancer Center
Thomas Jefferson University
Title of talk: New Developments in Cancer Research
Dr. Hamsa Thayele Purayil completed his Ph.D. from Mahatma Gandhi University, Kerala, India in 2011. He completed his M.S. Biotechnology from Cochin University of Science and Technology, India in 2002.
Over the last decade, his work focused on the initiation and progression of human cancers. His particular interest is to unveil novel cancer cell signaling pathways, identify potential therapeutic targets/ biomarkers, and develop treatment options/potential drugs. He has been involved in crucial discoveries that unraveled novel mechanisms in human prostate and kidney cancers. His career goal is to continue his passion through the industrial or academic environment and benefit patients. He has a broad background in medical science research with specific training and expertise in pharmacology, biochemistry, cell biology, and molecular biology. He is a self-motivated and innovative research scientist with a specialization in pharmacology, cell biology, biochemistry, and molecular biology.
He has extensive experiences in scientific writing with more than 20 peer-reviewed scientific publications in high-impact journals including PNAS, Oncogene, Cancer Research, Scientific Reports, Cancer Letters, JBC, etc.